Daiichi Sankyo and Merck & Co (MSD) have voluntarily withdrawn their biologics license application (BLA) for ifinatamab deruxtecan, aimed at...
Firefly Neuroscience and NeuroSigma have partnered to bring Monarch eTNS System for paediatric ADHD to clinicians.The post Firefly to offer...
Innovent Biologics has announced an expansion of its global Phase III MarsLight-11 trial evaluating IBI363, also known as TAK-928, to...
The US FDA has granted breakthrough device designation to Glytec’s proposed insulin dosing recommendation algorithm, Glucommander Pediatrics, for hospitalised newborns...
Clywedog Therapeutics has reported final results from a Phase Ib trial of its investigational oral drug balomenib in adults with...
The US FDA has approved Eli Lilly and Company’s Onswik, a once-weekly basal insulin injection for adults with type 2...
Precision Diabetes has signed a US commercialisation partnership with DirectSens for the MetMark clinical test, which measures AHB; 2-HB, a...
Roivant has announced top-line results from the first period of a proof-of-concept clinical study evaluating IMVT-1402 to treat CLE.The post...
Basecamp Research has secured $140m in a Series C funding round to train a new generation of its EDEN biological...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.